Press Release

LiveDrop Featured in Le Figaro! We are thrilled to announce that LiveDrop has been highlighted in Le Figaro, one of France's most prestigious newspapers, for our revolutionary contribution to biomedical research. The article, titled "LiveDrop: une technologie révolutionnaire pour la recherche biomédicale", showcases how our cutting-edge droplet microfluidic technology is transforming cell biology and microbiology. Read the full article here to learn more about how LiveDrop is pushing the boundaries of innovation in biomedical science. Stay tuned for more updates as we continue to make strides in advancing research and technology!

LiveDrop-Bio unveils ModaFlow 4L5C: Revolutionizing biotherapeutic discovery with picoscale droplet technology. LiveDrop is excited to announce the commercial launch of the new ModaFlow 4L5C, a cutting-edge picoscale droplet bioassay platform designed to advance precision cell and prokaryotes screening workflows, functional bioassays in drug discovery, and the exploration of single or multi-cell secretome. This groundbreaking instrument combines droplet microfluidics with unmatched precision and throughput, enabling researchers to screen extensive collections of cells far faster and more efficiently than traditional 96 or 384-well formats.

🚀 Exciting News from LiveDrop! 🚀 We are thrilled to announce that LiveDrop has officially partnered with MicroOmix, a Strasbourg-based pioneer in high-throughput cell screening. Together, we are set to help antibody discovery with a solution that promises to significantly reduce screening times and accelerate the development of treatments for cancers, neurodegenerative, and autoimmune diseases. 💡🔬 This strategic collaboration combines the disruptive technologies of both companies, merging LiveDrop's expertise in microfluidic instruments and MicroOmix's patented chemistry to drive faster, more targeted antibody discovery—unlocking the full potential of antibody-based therapies. Learn more about this game-changing partnership and how we are transforming the future of biomedical innovation.